GoodRx Holdings Files 8-K for Shareholder Vote Matters
Ticker: GDRX · Form: 8-K · Filed: Jun 7, 2024 · CIK: 1809519
| Field | Detail |
|---|---|
| Company | Goodrx Holdings, Inc. (GDRX) |
| Form Type | 8-K |
| Filed Date | Jun 7, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-meeting
Related Tickers: GDRX
TL;DR
GoodRx is calling for a shareholder vote on important company matters.
AI Summary
On June 6, 2024, GoodRx Holdings, Inc. filed an 8-K report detailing the submission of matters to a vote of its security holders. The filing indicates that the company is preparing for a shareholder vote on certain corporate matters. The exact nature of these matters and the date of the vote are not specified in this particular filing.
Why It Matters
This filing signals that GoodRx is engaging its shareholders in corporate decision-making, which could impact the company's future direction and governance.
Risk Assessment
Risk Level: low — The filing is procedural and does not disclose new financial risks or significant operational changes.
Key Players & Entities
- GoodRx Holdings, Inc. (company) — Registrant
- June 6, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Santa Monica, California (location) — Principal Executive Offices
FAQ
What specific matters will be presented for a vote to GoodRx Holdings, Inc. security holders?
This 8-K filing does not specify the exact matters to be voted on by security holders; it only reports that such matters are being submitted for a vote.
When is the shareholder vote scheduled to take place?
The filing does not provide a specific date for the shareholder vote.
What is the purpose of submitting these matters to a vote?
The purpose is to obtain shareholder approval or input on corporate matters as required by law or company governance.
Where are GoodRx Holdings, Inc.'s principal executive offices located?
GoodRx Holdings, Inc.'s principal executive offices are located at 2701 Olympic Boulevard, Santa Monica, California.
Under which section of the Securities Exchange Act of 1934 is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 733 words · 3 min read · ~2 pages · Grade level 13.5 · Accepted 2024-06-07 17:00:21
Key Financial Figures
- $0.0001 — hich registered Class A Common Stock, $0.0001 par value per share GDRX The Nasda
Filing Documents
- gdrx-20240606.htm (8-K) — 78KB
- 0001809519-24-000104.txt ( ) — 203KB
- gdrx-20240606.xsd (EX-101.SCH) — 2KB
- gdrx-20240606_lab.xml (EX-101.LAB) — 21KB
- gdrx-20240606_pre.xml (EX-101.PRE) — 12KB
- gdrx-20240606_htm.xml (XML) — 3KB
07 . Submission of Matters to a Vote of Security Holders
Item 5.07 . Submission of Matters to a Vote of Security Holders On June 6, 2024, GoodRx Holdings, Inc. (the "Company") held its Annual Meeting of Stockholders. Holders of the Company's Class A common stock were entitled to one vote per share held as of the close of business on April 8, 2024 (the "Record Date") and holders of the Company's Class B common stock were entitled to ten votes per share held as of the Record Date. A total of 79,472,296 shares of the Company's Class A common stock and 278,619,320 shares of the Company's Class B common stock were present in person or represented by proxy at the meeting, representing approximately 98.7% of the combined voting power of the Company's Class A and Class B common stock as of the Record Date. The following are the final voting results for the proposals considered and voted upon at the meeting, each of which were described in the Company's Definitive Proxy Statement filed with the Securities and Exchange Commission on April 25, 2024. Item 1 — Election of three Class I directors for a term of office expiring on the date of the Annual Meeting of Stockholders to be held in 2027 and until their respective successors have been duly elected and qualified or until their respective earlier death, resignation or removal. Votes FOR Votes WITHHELD Broker Non-Votes Douglas Hirsch 2,818,730,487 9,200,943 37,734,066 Kelly J. Kennedy 2,827,444,912 486,518 37,734,066 Agnes Rey-Giraud 2,818,445,912 9,485,518 37,734,066
— Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public
Item 2 — Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 2,865,260,377 336,904 68,215 0
— Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers
Item 3 — Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 2,823,670,920 4,151,594 108,916 37,734,066 Based on the foregoing votes, the Company's stockholders (i) elected Douglas Hirsch, Kelly J. Kennedy and Agnes Rey- Giraud as Class I directors; (ii) ratified the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024; and (iii) approved, on an advisory (non- binding) basis, the compensation of the Company's named executive officers. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GOODRX HOLDINGS, INC. Date: June 7, 2024 By: /s/ Karsten Voermann Name: Karsten Voermann Title: Chief Financial Officer